We are live on ! Find out more
CELG.RT

Bristol-Myers Squibb Rights
CELG.RT

20 hedge funds and large institutions have $67K invested in Bristol-Myers Squibb Rights in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 20 → 20 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.02% less ownership

Funds ownership: 0.05% → 0.02% (-0.02%)

99% less capital invested

Capital invested by funds: $6.42M → $67K (-$6.35M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
20
Holders Change
–
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$1.62K
2
UBS Group
UBS Group
Switzerland
+$490
3
Bank of America
Bank of America
North Carolina
+$8
4
WT
Whittier Trust
California
+$1

Top Sellers

Rank Fund Capital Flow
1
FCM
FourWorld Capital Management
New York
-$5.66M
2
M
Murchinson
Ontario, Canada
-$700K
3
TCA
Transcend Capital Advisors
New Jersey
-$378
4
TSS
Two Sigma Securities
New York
-$20
Name Holding Trade Value Shares
Change 		Change in
Stake
MS
1
Maven Securities
Jersey
$46.8K – – –
TCA
2
Transcend Capital Advisors
New Jersey
$5.46K -$378 -8,600 -7%
DC
3
Davenport & Co
Virginia
$4.2K – – –
Bank of America
4
Bank of America
North Carolina
$2.59K +$8 +180 +0.3%
Citadel Advisors
5
Citadel Advisors
Florida
$1.85K +$1.62K +36,922 New
PCA
6
Purkiss Capital Advisors
Connecticut
$1.32K – – –
TSS
7
Two Sigma Securities
New York
$1.28K -$20 -465 -2%
Fifth Third Bancorp
8
Fifth Third Bancorp
Ohio
$1K – – –
WGC
9
Watts Gwilliam & Co
Arizona
$1K – – –
PAG
10
Private Advisor Group
New Jersey
$750 – – –
UBS Group
11
UBS Group
Switzerland
$659 +$490 +11,152 +555%
Northwestern Mutual Wealth Management
12
Northwestern Mutual Wealth Management
Wisconsin
$17 – – –
RIL
13
Rothschild Investment LLC
Illinois
$8 – – –
Morgan Stanley
14
Morgan Stanley
New York
$6 – – –
OC
15
Oakworth Capital
Alabama
$6 – – –
AEPWM
16
Atlantic Edge Private Wealth Management
Florida
$1 – – –
JP Morgan Chase
17
JP Morgan Chase
New York
$1 – – –
Wells Fargo
18
Wells Fargo
California
$1 – – –
WT
19
Whittier Trust
California
$1 +$1 +25 New
M
20
Murchinson
Ontario, Canada
– -$700K -400,000 Closed
FCM
21
FourWorld Capital Management
New York
– -$5.66M -100,000 Closed

CELG.RT Hedge Fund Activity: Q1 2025 in Review

20 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q1 2025, worth a combined $67K — down 99% from $6.42M a quarter earlier.

Fund positioning in CELG.RT was balanced in Q1 2025: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $1.62K. The largest seller was FourWorld Capital Management, exiting entirely with an estimated $5.66M sold.

  • 20 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $67K of Bristol-Myers Squibb Rights stock for Q1 2025, down 99% quarter-over-quarter.
  • 2 funds opened new Bristol-Myers Squibb Rights positions in Q1 2025 and 2 closed out, a net change of 0 holders.
  • The largest Bristol-Myers Squibb Rights buyer in Q1 2025 was Citadel Advisors, an estimated $1.62K added.
  • The largest Bristol-Myers Squibb Rights seller in Q1 2025 was FourWorld Capital Management, an estimated $5.66M sold.

Based on aggregated 13F filings for Q1 2025.